Modified CEUS criteria using perfluorobutane can help diagnose high-risk hepatocellular carcinoma

AI nuclear energy background, future innovation of disruptive technology

According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), diagnostic performance of LR-5 for hepatocellular carcinoma (HCC) diagnosis was not significantly different between modified contrast-enhanced ultrasound (CEUS) using perfluorobutane and CT/MRI LI-RADS version 2018.

Gossypetin found in hibiscus may help combat Alzheimer’s disease

Previous article

Facebook reminds employees: You can’t fact check Trump now that he’s running for president

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News